| PERIOD ENDING | 5-Apr-09 | 28-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 431,574 | 421,369 | 505,117 | 528,636 | | Cost of Revenue | 243,619 | 219,641 | 293,957 | 308,996 | | | Gross Profit | 187,955 | 201,728 | 211,160 | 219,640 | | | Operating Expenses | | Research Development | 25,973 | 21,528 | 27,526 | 29,890 | | Selling General and Administrative | 128,414 | 116,666 | 131,118 | 143,022 | | Non Recurring | 7,823 | (719) | 7,214 | (305) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,745 | 64,253 | 45,302 | 47,033 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (249) | (22,514) | 321 | 798 | | Earnings Before Interest And Taxes | 25,496 | 41,739 | 45,623 | 47,831 | | Interest Expense | 4,588 | 6,787 | 6,371 | 5,746 | | Income Before Tax | 20,908 | 34,952 | 39,252 | 42,085 | | Income Tax Expense | 5,847 | 7,734 | (4,506) | 10,339 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,061 | 27,218 | 43,758 | 31,746 | | | Non-recurring Events | | Discontinued Operations | (4,502) | 3,445 | 8,144 | (8,040) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,559 | 30,663 | 51,902 | 23,706 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,559 | $30,663 | $51,902 | $23,706 |
|
0.45% Nasdaq 
0.20%
Income Statement
